A Study to Evaluate the Efficacy and Safety of Prothione™ Capsules for Mild to Moderate Coronavirus Disease 2019 (COVID-19)
Condition(s):Coronavirus Disease 2019 (COVID-19)Last Updated:April 21, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Coronavirus Disease 2019 (COVID-19)Last Updated:April 21, 2022Completed
Condition(s):Coronavirus; Coronavirus Sars-Associated as Cause of Disease Classified ElsewhereLast Updated:November 30, 2020Completed
Condition(s):CoronavirusLast Updated:July 14, 2022Completed
Condition(s):COVID-19Last Updated:June 6, 2023Recruiting
Condition(s):COVID; Corona Virus Infection; Covid-19; SARS-CoV-2 InfectionLast Updated:March 24, 2022Completed
Condition(s):Middle East Respiratory Syndrome CoronavirusLast Updated:December 1, 2020Completed
Condition(s):COVID-19; Coronavirus Infections; Respiratory Tract Infections; COVID-19 Respiratory InfectionLast Updated:August 30, 2023Active, not recruiting
Condition(s):CoronavirusLast Updated:March 31, 2020Unknown status
Condition(s):Coronavirus InfectionLast Updated:April 1, 2021Terminated
Condition(s):COVID-19Last Updated:February 15, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.